Lithuania vs Tuvalu: Previously treated cases tested for RR-/MDR-TB
Lithuania
100.0%
in 2024
Tuvalu
100.0%
in 2021
Lithuania rank
1st
Tuvalu rank
1st
Previously treated cases tested for RR-/MDR-TB over time
- Lithuania
- Tuvalu
How they compare
Lithuania currently reports 100.0% against 100.0% in Tuvalu, a difference of 0.0%.
The two have swapped places 1 time across 6 shared years of data; in 2014 it was Lithuania ahead.
Lithuania ranks 1st and Tuvalu ranks 1st of 180 countries.
Lithuania has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Lithuania | Tuvalu | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 100.0% | 36.8% | 63.2% | Lithuania |
| 2020s | 100.0% | 100.0% | 0.0% | — |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher previously treated cases tested for rr-/mdr-tb, Lithuania or Tuvalu?
- Lithuania, at 100.0% against 100.0% in Tuvalu as of 2024.
- What is the difference in previously treated cases tested for rr-/mdr-tb between Lithuania and Tuvalu?
- 0.0%, with Lithuania ahead.
- How many years of comparable data are there for Lithuania and Tuvalu?
- 6 years are reported by both, from 2014 to 2021.
- How do Lithuania and Tuvalu rank globally for previously treated cases tested for rr-/mdr-tb?
- Lithuania ranks 1st and Tuvalu ranks 1st of 180 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Previously treated cases tested for RR-/MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.